Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18760089 | 0.82 | HTR6 (0.41) | CA1CA2CA12CA9CA3 | |
| SCHEMBL17891971 | 0.79 | ALDH1A1 (0.42) | GAACA1CA2CA12CA9 | |
| SCHEMBL9341811 | 0.78 | GAA (0.48) | GAACA1CA2CA12CA9 | |
| SCHEMBL5212059 | 0.78 | GAA (0.48) | GAACA1CA2CA12CA9 | |
| SCHEMBL273450 | 0.77 | CA12 (0.41) | GAACA1CA2CA12CA9 | |
| SCHEMBL31249552 | 0.75 | VDR (0.40) | GAACA1CA2CA12CA9 | |
| SCHEMBL6490 | 0.73 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| SCHEMBL7186972 | 0.73 | GAA (0.59) | GAACA1CA2CA12CA9 | |
| Acetonitrile SCHEMBL28199329 | 0.72 | GAA (0.46) | GAACA1CA2CA12CA9 | |
| SCHEMBL4801283 | 0.72 | CYP1A2 (0.44) | GAACA1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420649-A | Preparation method and application of novel COX-2 targeted near infrared fluorescent molecular probe | 西南医科大学附属医院 | 2024-08-02 | — | — | CN | claimed |
| CN-117843928-A | Controllable synthesis and application of optically active spiral poly-carbene containing adamantane side group in construction of supermolecular polymer brush | 合肥工业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117335006-A | Lithium ion battery electrolyte and preparation method and application thereof | 柳州法恩赛克新能源科技有限公司 | 2024-01-02 | — | — | CN | claimed |
| CN-111100227-B | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-109438380-B | Method for synthesizing 4- (N, N-dialkyl-2-propyne-1-amino) isoxazole | 华南理工大学 | 2022-04-22 | — | — | CN | claimed |
| CN-109873204-B | Ternary lithium ion battery electrolyte and lithium ion battery containing same | 杉杉新材料（衢州）有限公司 | 2020-11-06 | — | — | CN | claimed |
| CN-111100227-A | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-109438380-A | A kind of method of synthesis 4- (N, N- dialkyl group -2- propine -1- amino) isoxazole | 华南理工大学 | 2019-03-08 | — | — | CN | claimed |
| CN-109180737-A | Phototoxicity organic compound and its preparation method and application for treating liver cancer | 广西中医药大学 | 2019-01-11 | — | — | CN | claimed |
| CN-109180740-A | The aryl ruthenium complex and its preparation method and application for treating inflammation | 广西师范学院 | 2019-01-11 | — | — | CN | claimed |
| CN-109096340-A | Compound and its preparation method and application for treating inflammation | 广西中医药大学 | 2018-12-28 | — | — | CN | claimed |
| CN-109021029-A | Compound and its preparation method and application for treating gastric cancer | 广西中医药大学 | 2018-12-18 | — | — | CN | claimed |
| CN-108864202-A | Compound and its preparation method and application for treating liver cancer | 广西中医药大学 | 2018-11-23 | — | — | CN | claimed |
| CN-108752390-A | With phototoxic antitumoral compounds and its preparation method and application | 广西中医药大学 | 2018-11-06 | — | — | CN | claimed |
| CN-105609877-A | High-voltage lithium ion battery electrolyte and high-voltage lithium ion battery | DONGUAN KAIXIN BATTERY MAT CO LTD | 2016-05-25 | — | — | CN | claimed |
| CN-121377950-A | Preparation method of insect sex pheromone (8E, 10E) -dodecene-1-alcohol | 石家庄学院 | 2026-01-23 | — | — | CN | disclosed |
| CN-119161329-A | Novel targeted near infrared fluorescent probe NFA-NIR-Cys and preparation method and application thereof | 西南医科大学附属医院 | 2024-12-20 | — | — | CN | disclosed |
| US-20050245607-A1 | N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides | SYNGENTA CROP PROTECTION, INC. | 2005-11-03 | — | — | US | disclosed |
| EP-1534664-A1 | N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES | Syngenta Participations AG (CH) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004011417-A1 | N-BISARYL- AND N-ARYL-CYCLOALKYLIDENYL-ALPHA-HYDROXY-AND ALPHA-ALKOXY ACID AMIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2004-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245607-A1 | N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides | CBR3, CBR1, AKR1C3 | GAA 2064/4885CA1 765/4885CA2 1478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.